The ROC analyses, even performed on a limited number of samples, identified the cut-off levels of CDH1, CDH5, and ZEB1 genes useful for the possible diagnostic identification of primary or metastatic tumors. This evidence concerns the gene CDH5 and metastatic neoplasm.